The Health Care Blog

The FDA Steps In: Regulating Prescription Drug Promotion on the Internet

By KATE GREENWOOD The FDA has been widely criticized for not providing guidance for drug companies eager to promote their products on the internet. Earlier this year, the FDA expressed the view that the message was what was important, not...
November 12, 2009 in FDA, Social Media | Permalink | Comments (1)

Drug Suspected in Michael Jackson Death Subject of Recall

By SHERI FINK Results of Michael Jackson’s toxicology tests have not yet been released, but suspicions have centered on the powerful anesthetic and sedative drug propofol, also known by the brand name Diprivan. It was reportedly found in Jackson’s house,...
July 3, 2009 in CDC, FDA, pharmaceuticals | Permalink | Comments (4)

Daschle out at HHS - Sharfstein in at FDA?

By MERRILL GOOZNER The early stages of the Obama administration are beginning to resemble the Clinton years, which I observed from afar (I was a foreign correspondent in Tokyo at the time). Take Zoe Baird and substitute Tom Daschle, who...
February 6, 2009 in FDA, HHS, Merrill Goozner | Permalink | Comments (21)

Should the FDA relax in the search for new cures?

By Matthew Holt Over at DiabetesMine #1 health blogger Amy Tenderich has very important post. She and several fellow travelers are appealing to the FDA to strike a balance between safety and progress in allowing new diabetes treatments. The FDA...
January 9, 2009 in e-patients, FDA, Health 2.0, Patient Safety, Pharma, pharmaceuticals | Permalink | Comments (1)

Who should Obama pick for FDA Commissioner?

By John Mack It seems like everyone in the Pharma Blogosphere and the press is recommending who president-elect Barack Obama should nominate as the new FDA Commissioner to replace Dr. Andrew von Eschenbach. A few weeks ago, I created the...
December 10, 2008 in FDA, Pharma | Permalink | Comments (8)

Americans' Confidence in the FDA Falls Sharply

By Jane Sarasohn-Kahn Confidence in the FDA has hit bottom. The latest survey on trust in the FDA comes from Harris Interactive, who regularly surveys the public's faith in the regulator. Consumers see the FDA's #1 job as "ensuring the...
April 23, 2008 in FDA | Permalink | Comments (7)

WSJ Editorial on Liver Transplants Cherry-Picks the Numbers - Maggie Mahar

Dr. Scott Gottlieb, a resident fellow at the conservative American Enterprise Institute, published an op-ed in the Wall Street Journal last week that returned to the much-exploited story of Nataline Sarkisyan, the 17-year-old Californian who died before receiving a liver...
January 16, 2008 in FDA, Maggie Mahar, Policy | Permalink | Comments (11)